Poh Yi Gan
Targeted Nanomedicines Group
Dr Poh-Yi Gan is an NHMRC Research Fellow and Head of the Targeted Nanomedicines Group at the Centre for Inflammatory Diseases, Monash University. She completed her PhD in 2014 at Monash University under the supervision of Prof Stephen Holdsworth to study the role of CD4+ T cell subsets in autoimmune kidney disease. Dr Gan is funded by NHMRC, Department of Health Medical Research Future Fund, Heart Foundation and School of Clinical Sciences at Monash Health.
Dr Gan’s research program focuses on discovering injurious cellular effector mediators that can be specifically targeted using biologicals and developing novel therapeutics capable of inducing antigen specific tolerance in autoimmune kidney disease. To find out more see Dr Poh Yi Gan's Monash profile.